Scientists regenerate neurons in mice with spinal cord injury and optic nerve damage
New research by scientists at the Lewis
Katz School of Medicine Temple University (LKSOM) shows, however, that gains in
functional recovery from these injuries may be possible, thanks to a molecule
known as Lin28, which regulates cell growth. In a study published online in the
journal Molecular Therapy, the
Temple researchers describe the ability of Lin28 -- when expressed above its
usual levels -- to fuel axon regrowth in mice with spinal cord injury or optic
nerve injury, enabling repair of the body's communication grid.
"Our findings show
that Lin28 is a major regulator of axon regeneration and a promising
therapeutic target for central nervous system injuries," explained Shuxin
Li, MD, PhD, Professor of Anatomy and Cell Biology and in the Shriners
Hospitals Pediatric Research Center at the Lewis Katz School of Medicine at
Temple University and senior investigator on the new study. The research is the
first to demonstrate the regenerative ability of Lin28 upregulation in the
injured spinal cord of animals.
"We became interested
in Lin28 as a target for neuron regeneration because it acts as a gatekeeper of
stem cell activity," said Dr. Li. "It controls the switch that
maintains stem cells or allows them to differentiate and potentially contribute
to activities such as axon regeneration."
To explore the effects of
Lin28 on axon regrowth, Dr. Li and colleagues developed a mouse model in which
animals expressed extra Lin28 in some of their tissues. When full-grown, the
animals were divided into groups that sustained spinal cord injury or injury to
the optic nerve tracts that connect to the retina in the eye.
Another set of adult mice,
with normal Lin28 expression and similar injuries, were given injections of a
viral vector (a type of carrier) for Lin28 to examine the molecule's direct
effects on tissue repair.
Extra Lin28 stimulated
long-distance axon regeneration in all instances, though the most dramatic
effects were observed following post-injury injection of Lin28. In mice with
spinal cord injury, Lin28 injection resulted in the growth of axons to more
than three millimeters beyond the area of axon damage, while in animals with
optic nerve injury, axons regrew the entire length of the optic nerve tract.
Evaluation of walking and sensory abilities after Lin28 treatment revealed
significant improvements in coordination and sensation.
"We observed a lot of
axon regrowth, which could be very significant clinically, since there
currently are no regenerative treatments for spinal cord injury or optic nerve
injury," Dr. Li explained.
One of his goals in the
near-term is to identify a safe and effective means of getting Lin28 to injured
tissues in human patients. To do so, his team of researchers will need to
develop a vector, or carrier system for Lin28, that can be injected systemically
and then hone in on injured axons to deliver the therapy directly to multiple
populations of damaged neurons.